Brief: Gb Sciences Inc - Reported Positive Results From A Study Of Its Potential Treatment For Cytokine Release Syndrome
06/12/2021 12:50
Dec 6 (Reuters) - GB Sciences Inc GBLX.PK :
* GB SCIENCES INC - REPORTED POSITIVE RESULTS FROM A STUDY
OF ITS
POTENTIAL TREATMENT FOR CYTOKINE RELEASE SYNDROME
* GB SCIENCES INC - GB SCIENCES TEAM PLANS TO MOVE QUICKLY
THROUGH
DEVELOPMENT STAGES FOR NOVEL CRS THERAPY
Source text for Eikon: ID:nGNX2K3Tm1
Further company coverage: GBLX.PK
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on GB Sciences
See all newsBrief: Gb Sciences' Plant-Based Formulations Designed To Treat Anxiety Achieve Statistical Significance In Animal Study
Brief: Gb Sciences Inc - Reported Positive Results From A Study Of Its Potential Treatment For Cytokine Release Syndrome
Brief: GB Sciences Sells Its Louisiana Medical Marijuana Business
Brief: GB Sciences Files Novel Patent Application
Brief: GB Sciences Announces The Appointment Of John Davis As Executive VP And General Counsel